Innovation Pharmaceuticals Inc (OTCMKTS: IPIX) is moving steadily northbound with power after the Company reported Brilacidin, its defensin-mimetic drug candidate exhibiting broad-spectrum antiviral activity, inhibited the...
IPIX (Innovation Pharmaceuticals) is making a major run up the charts in recent weeks making a move towards its June highs of $0.65 per share on...
Innovation Pharmaceuticals Inc (OTCMKTS: IPIX) is heading northbound after the Company along with George Mason University reported testing results demonstrated Brilacidin’s COVID-19 Treatment Potential. In a...
Innovation Pharmaceuticals Inc (OTCMKTS: IPIX) is spiking northbound after the Company reported it received additional data from a U.S. Regional Biocontainment Laboratory (RBL) collected during ongoing...
Innovation Pharmaceuticals Inc (OTCMKTS: IPIX) is fast emerging as one of the most exciting stocks in small caps as Brilacidin continues to show significant progress in...
Innovation Pharmaceuticals Inc (OTCMKTS: IPIX) has skyrocketed in recent days after the Company announced Data From Ongoing Testing at U.S. Regional Biocontainment Laboratory shows Brilacidin Inhibits...
